Abstract. Superparamagnetic iron oxide nanoparticles (MNPs) have recently been investigated for their excellent biocompatibility as well as multi-purpose biomedical potential with promising results, owing to their ability to be targeted and heated by magnetic fields. In this study, novel hydrogel, chitosan Fe 3 O 4 magnetic nanoparticles were synthesized for possible use for induced magnetic hyperthermia, and targeted drug delivery. The coating of iron oxide nanoparticles plays a key-role to efficiently improve internalization of nanoparticles in many cell types. Targeting is also highly desirable for these applications. In this regard hydrophilic coating like chitosan was used to improve drug release. Uncoated (Fe 3 O 4 )and chitosan-coated iron oxide nanoparticles (CS-Fe 3 O 4 ) were synthesized and characterized from the biological point of view. The aim of this study was to provide an in vitro evaluation of the cytocompatibility of Fe 3 O 4 and CS-Fe 3 O 4 MNPs by using different in vitro evaluation tests.In this context, the cytocompatibility and cytotoxic effects of uncoated and hydrogel chemically-engineered chitosan-coated iron oxide NPs were investigated according to the ISO standard 10993-5:2009. Fe 3 O 4 and CS-Fe 3 O 4 NPs were tested on human mammary epithelial cells (MCF-10A) by using direct and not direct contact cytotoxicity evaluation tests, by evaluating influence of the iron particles on the cytoskeleton with phalloidin/DAPI staining and in vitro cellular iron uptake with Perl's Prussian blue staining. The results indicate that uncoated and chitosan-coated iron oxide nanoparticles are cytocompatible, without negative influence on the cytoskeleton or higher accumulation of iron in the cytoplasm. Therefore, it is encouraging that our data suggest uncoated and chitosan-coated iron oxide nanoparticles have satisfactory proliferative and viability effects on MCF-10A cells. In conclusion data suggest that both MNP types may be differently aimed in biomedical application in relation to the dose, acting as biocompatible materials, as component of scaffolds, or as a device for theranostics.
INTRODUCTION
Nanomaterial structures with dimensions between 1 and 100 nm are currently used for medical applications; such as magnetic drug targeting, hyperthermia, and enhanced resolution magnetic resonance imaging [1] . Nanomedicine formulations aim at improving distribution and accumulation at the target sites [2] . Hence, nanomaterials could improve the therapeutic index of low molecular weight drugs and provide more effective and less toxic treatment [3] . However, levels of inorganic nanoparticles (NPs) have already increased in ambient air and have impacted public health [1, 2, 4] . Previous studies revealed that NP, such as iron oxide NPs, can enter into cells and accumulate in mitochondria, vesicles, phagosomes and lysosomes [5, 6] . The use of magnetic nanoparticles (MNPs) is gaining ground in various industrial domains [7] . Iron oxide nanoparticles are the most commonly used magnetic nanoparticles and their use shows promise in a number of biomedical applications. The use of MNPs for delivery of drugs is also promising. When an external magnetic field and field gradient are applied, active ingredients bound to or incorporated in these particles are successfully carried to the desired site with relatively high accuracy, minimum surgical intervention, maximum dose, and avoidance of toxic side effects on other organs [8] . Because of the possibility of inducing magnetization by applying an external magnetic field, thus directing them to a target site, and heating them by applying an external alternating current magnetic field, they are particularly promising for many biomedical applications and cancer therapy [9] . The precise control of the physiochemical and biological properties of these magnetic systems is crucial for their biomedical applications, as the induced heat is highly dependent on these properties and useful for targeting magnetic drug release.Due to their unique magnetic properties, excellent biocompatibility as well as multi-purpose biomedical potential superparamagnetic iron oxide nanoparticles (SPIONs) are attracting increasing attention in both pharmaceutical and industrial communities. These include both in vitro technologies (diagnostic separation, selection, and magnetorelaxometry) [10] , and in vivo innovative therapeutic (hyperthermia and drug-targeting) and diagnostic approaches (nuclear magnetic resonance -NMR-imaging) [11] . Iron oxide nanoparticles can be engineered with desired functionality. The techniques used for surface functionalization comprise grafting of or coating with organic species, including surfactants or polymers [12] .The coating of MNPs plays a key-role to efficiently improve internalization of NPs in many cell types. Targeting is also highly desirable for these applications. Strong magnetization and the ability to functionalize surfaces with targeting moieties are the keys to improve MNPs effectiveness. In this perspective we used a hydrophilic coating like chitosan to favor drug release in the target site. Chitosan is a deacetylated derivative of chitin, a positively charged natural polymer carrierfound in the shells of crustaceans, and is structurally similar to hyaluronic acid (extracellular matrix) [13, 14] . The biomedical applications of chitosan have been studied for over 40 years [13] . The excellent properties of chitosan, including its biocompatibility, bioactivity, biodegradability, and nontoxic byproducts make it easy to functionalize for biomedical applications [13] . The cell adhesion and potential uptake of chitosan particles are also most favorable due to their attraction to negatively charged cell membranes, an attractive feature for the treatment of solid tumors [15] . Moreover, chitosan has shown favorable biocompatibility [16] as well as the ability to increase cell membrane permeability both in vitro and in vivo [17] . Among the various biopolymers, chitosan along with nanoparticles has been utilized as a stabilizing agent due to its excellent film-forming ability, mechanical strength, biocompatibility, non-toxicity, high permeability towards water, susceptibility to chemical modifications, cost-effectiveness [18] . So the chitosan layer in the magnetic nanoparticles is useful for the functionalization and the biocompatibility of this type of nanoparticles, in particular by avoiding the possible release of toxic substances from the core of magnetite (Fe 3 O 4 ) crystalline structure. In this context, we examined the cytotoxic effects of uncoated and hydrogel chemically-engineered chitosan-coated iron oxide NPs by using different in vitrodirect and not direct evaluation tests of cell biocompatibilityby evaluating influence of the iron particles on the cytoskeleton with phalloidin/DAPI staining and in vitro cellular iron uptake with Perl's Prussian blue staining.
MATERIALS AND METHODS

Synthesis of Iron Oxide Nanoparticles
Magnetic iron oxide nanoparticles (Fe 3 O 4 ) were prepared by alkaline co-precipitation of ferrous chloride tetrahydrate, FeCl 2 •4H 2 O (1.34 g) (Sigma-Aldrich) and ferric chloride hexahydrate FeCl 3 •6H 2 O (3.40 g)(SigmaAldrich) at 1:2 ratio. The salts were dissolved in 150 mL deionized water within a three necked glass balloon. The glass balloon was placed in a heating mantle and stirred with a magnetic stirrer. It was vigorously stirred at 90ºC in the presence of N 2 gas. Ammonium hydroxide (NH 4 OH) (Sigma-Aldrich) was added to the system drop wise. The process was ended by washing with deionized water until the solution pH was 9.0. The solution was then centrifuged at 5000 rpm for 30 minutes. The precipitates were collected and dried in the incubator (Thermo Fisher Scientific, Waltham, Massachusetts, U.S.) at 55ºC. The black precipitates were then turned into brown.
Synthesis of Chitosan-coated Magnetic Iron Oxide Nanoparticles
Chitosan-coated magnetic iron oxide nanoparticles (CS-Fe 3 O 4 ) were in situ synthesized by the co-precipitation of Fe (II) and Fe (III) salts in the presence of chitosan (Sigma-Aldrich) and trisodium phosphate molecules (SigmaAldrich). Chitosan was previously prepared with degree of deacetylation 75% by titrimetric method [19] . Trisodium phosphate was used for the crosslinking of low molecular weight chitosan polymers. Chitosan (0.15 g) was dissolved in 30 ml of 1% acetic acid (Sigma-Aldrich) and the pH was adjusted to 4.8 by 10M NaOH (SigmaAldrich). Iron salts (1.34 g FeCl 2 •4H 2 O and 3.40 g FeCl 3 •6H 2 O) were dissolved in 30 ml of 0.5% chitosan solution. The solution was then vigorously stirred at 2000 rpm. 10 ml of 22.5% trisodium phosphate and different amounts of 32% NH 4 OH (18, 20, 22, 25 mL) (Sigma-Aldrich) were added to the solution to obtain the final NH 4 OH concentration of 31%, at room temperature. The ammonia solution was added very slowly to produce smaller sized nanoparticles. The resulting solution was stirred for an additional 1 hour. The colloidal chitosan coated magnetic Fe 3 O 4 nanoparticles were extensively washed (3 times) with deionized water and separated by centrifugation and drying.
Cell cultures
Human mammary epithelial cells (MCF 10A, ATCC, CRL-10317) was cultivated in Mammary Epithelial Cell Growth Medium (MEGM, Lonza/Clonetics) supplemented with 2 mM L-glutamine(Lonza/Clonetics), 100 ng/ml cholera toxin (Sigma-Aldrich), 10% fetal bovine serum (FBS, Gibco, Thermo-Fisher, Pittsburg, PA, US) and 1% antibiotics/antimycotics (penicillin/streptomycin/gentamycin, Gibco) (complete medium). Cells were incubated in a humidified 5% CO 2 atmosphere at 37°C and passaged twice weekly at a 1:4-5 concentration.
Lactate dehydrogenase assay
The effect of the NPs on the integrity of the cell membrane was assayed using a LDH Cytotoxicity Assay Kit (Gesan group, Italy). The assay was performed as per the manufacturer's instructions. LDH is released by cells in response to damage or loss of integrity of cell membrane and is a cellular toxicity indicator. Briefly, 1.6 ×10 4 MCF-10A cells/well were seeded in 24-well plates and treated with the following concentrations of MNPs: 10 g/ml, 20 g/ml, 40 g/ml and 80 g/ml (w/v) for 24, 48 and 72 hours. Untreated cells were taken as the negative control and cells was used to validate the assay. Following the incubation with NPs, the well plates were centrifuged at 600 g for 10 minutes an -well plate. The medium was then incubated with 100 the microplate reader (Victor X4 -PerkinElmer) with the reference wavelength at 650 nm. LDH was quantified using the following formula:
(1) in which "low control" was the cells without any treatment and "high control" was the cells treated with lysis buffer (total LDH).
Direct contact cytotoxicity evaluation
Direct static contact cytotoxicity of MNPs was evaluated following the ISO standard 10993-5:2009 on Biological Evaluation of Medical Devices instructions [3] . Cells were seeded in 24-well plates (1.6 x 10 4 cells per well) in complete MEGM medium and incubated for 24 h at 37°C in 5% CO 2 . Medium containing MNPs at 10, 20, 40 and NPs was used as control. Cell viability was evaluated after 24, 48 and 72 hoursby the (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide colorimetric assay (MTT, Sigma). specimen and incubated for 4 hours in the dark at 37°C; sulphoxyhde (DMSO, Sigmaoptical density (o.d.) was evaluated at 570 nm (Spectrophotometer, Packard Bell, Meriden, CT, USA). The mean optical densities obtained from control specimens were taken as 100% viability. Cell viability was calculated as follow: (experimental o.d. / mean control o.d.)*100. Experiments were performed with four replicates at each experimental time.
Leaching toxicity tests of MNPs
For leaching toxicity tests the MNPs were sterilized with UV and MEGM culture medium containing 10% calf serum was then added to it in a sterile closed vessel (final concentration 0.1 g/mL). Leaching conditions were 37°C over 72 hours. The samples were then centrifuged at 2500 rpm for 5 minutes, the supernatant was removed by suction and filtered through a microporous filter (VWR International, U.S.) to provide a 100% leach solution.
During the test, the MEGM culture medium was diluted to the required concentration. MCF-10A cells were removed during their logarithmic growth phase and digested in the cell suspension; the cell concentration was next adjusted to 4 × 10 3 /mL and inoculated on a 96-well culture plat an incubator at 37°C under saturated humidity and 5% CO 2 conditions. The primary solution was discarded after 24 hours, at which time the leaching solution was added until the final concentration was 100%, 75%, 50%, and 25%. The MEGM culture inoculum was used as control. Each group comprising four wells was cultured for 72 hours, and nm using a spectrophotometer (Packard Bell, Meriden, CT, USA). The relative cell growth rate was calculated as follows: relative growth rate % = OD (Optical Density) mean value of test group/OD mean value of negative control group × 100%.
Cell morphology evaluation
Cells were seeded on glass coverslips (12 mm diameter) in 24-well plates, and after 24 h they were incubated with MNPs for 72 h at the concentrations described above. Cells were then fixed with 4% paraformaldehyde (SigmaAldrich) in phosphate buffered saline (PBS) for 20 minutes at 4 °C, washed 3 times with PBS, and permeabilized with 0.2% Triton X-100 (Sigma-Aldrich), 1% bovine serum albumin (BSA), and 5% goat serum in PBS for 2 h. Tetramethyl Rhodamine B isothiocyanate (TRITC)-Phalloidin (1/2000 in PBS, AbCam, Cambridge, UK) was added for 45 minutes at room temperature; specimens were then washed thrice more with PBS and nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich). ImmuoFluorescence(IF) images were acquired with fluorescent microscope (Leica AF 6500, Leica Microsystems, Basel, CH) at 20x magnification.
In vitro cellular iron uptake studies -Perl's Prussian blue staining
MCF-10A cells at a density of 5×10 5 cells/well were seeded onto the 12-well plate and incubated for 24 h, and 1 mL of the DMEM containing Fe 3 O 4 or CS-Fe 3 O 4 NPs incubated at 37°C for 24 h. After incubation the cells were fixed with 4% paraformaldehyde(PF). Then Perl's Prussian blue staining assay was performed according to the following method. The PB solution was prepared bymixing 3 mL of 2% potassium ferrocyanide (II)(Merck) with the same amount of 1% hydrochloricacid (Merck). The stain was then put on the cells atroom temperature for 20 min. Nuclear fast redaluminumsulphate staining(Sigma-Aldrich) was performed to colourthe nuclei.The wells without Fe 3 O 4 or CS-Fe 3 O 4 NPs were used as control. Perl's Prussian blue staining images were taken on an Olympus BX51 optical microscope at 100x magnification(Olympus Corp, Tokyo, Japan). Perls' Prussian blue was performed to control the intracellular accumulation of iron ions in mammary epithelial cells after contact with magnetic nanoparticles
Statistical analyses
All statistical analyses were performed using the IBM Statistical Package for Social Sciences v. 20 (SPSS -IBM, Chicago, MI, US). Multiple comparisons were analyzed using Levene's test, one way analysis of variance (ANOVA) followed by Scheffe's test. Two-samples comparisons were evaluated with the Mann-Whitney U test. P values < 0.05 were considered to be statistically significant.
RESULTS
Lactate dehydrogenase assay
The lactate dehydrogenase assay is able to evaluate cell damage, as indicated by lactate dehydrogenase release from the cytosol of lysed cells. LDH leakage from MNPs reflects cell membrane disruption. The lactate dehydrogenase results on MCF-10A cells were consistent with those of direct contact cytotoxicity (Fig. 1) . All types of MNPs stimulated LDH release in a concentration-dependent manner. LDH release of Fe 3 O 4 NPs and CS-Fe 3 O 4 NPs (in a range between 3.09 and 5.13%) was limited compared to control after 24, 48 and 72 hours, suggesting less cell membrane damage (Fig. 1) . Data were considered statistically significant (p < 0.05). 
Material toxicity testing of magnetic nanoparticles leach solution
The values of cell viability revealed no significant difference in MCF-10A cell growth compared with that in the control group after Fe 3 O 4 and CS-Fe 3 O 4 nanoparticle leaching solution (100%, 75%, 50%, and 25%) was added. The relative growth rate is shown in Table (Fig.2) . The cell viability after 72 hours (MTT assay) range between 82% and 94% for Fe 3 O 4 , 89% and 91% for CS-Fe 3 O 4 (Fig.2) . Fe 3 O 4 and CS-Fe 3 O 4 MNPs did not affect the viability of mammary epithelial cells in a range of concentration of MNPs from 10 to 80 μg/ml. Cell viability slightly decreased at higher concentrations, and for longer contact times. In all cases, viability was above 80%. These data of cell viability showed cytocompatibility and stability of the chitosan layer of nanoparticles comparable to control. 
Cell morphology evaluation
Compared to untreated controls, no morphological alterations of the cells were observed after direct contact with MNPs for 72 h (Fig. 3A) . IF staining allowed to observe a regular cell morphology of mammary epithelial cells in contact with magnetic nanoparticles respect to control (Fig.3A) . This indicates that iron-oxide nanoparticles haven't an adverse effect on cell morphologyand consequently on the cytoskeleton. As a further confirmation, cells fluorescence intensity (data not shown) was comparable between untreated controls and MNPs loaded cells and no statistically significant differences were noticed at each time-points (p>0.05). (Fig. 3B) . 
In vitro cellular iron uptake studies
DISCUSSION AND CONCLUSION
As nanotechnology has developed, several methods, both physical and chemical, have been proposed to prepare MNPs [7] . There are advantages and disadvantages to each method; moreover, information concerning the toxicity of MNPs is still incomplete, and different studies apply different test protocols, making their comparison difficult [7] . The ability of magnetic nanoparticles to be functionalized and concurrently respond to a magnetic field has made them a useful tool for theranostics -the fusion of therapeutic and diagnostic technologies that targets to individualize medicine [20] . Fe 3 O 4 are superior to other metal oxide nanoparticles for their non-toxicity, biocompatibility, magnetic properties and chemical stabilityand are, by far, the most commonly employed MNPs for biomedical applications. Recently, considerable research has been focused on iron oxides due to their potential uses such as magnetic drug targeting, magnetic resonance imaging for clinical diagnosis, recording material and catalysts [21] . Surface modification can stabilize magnetite nanoparticles in the physiological environment and functionalize them to make them responsive to the physical stimuli [22] . The relevance of the prepared chitosan-coated MNPs as a successful candidate for multifunctional nanoprobes is important for the delivery of the magnetic materials inside cellular environment.The aim of this study was to provide an in vitro evaluation of the cytocompatibility of Fe 3 O 4 and CS-Fe 3 O 4 MNPs Uncoated and chitosan-coated iron oxide nanoparticles were synthesized and characterized from the biological point of view. The results indicate that chitosan-coated iron oxide nanoparticles are cytocompatible.Chemotherapy drugs could be also loaded into chitosan-coated nanoparticles; the magnetic properties of these nanoparticles can be utilized to target the infective focus, resulting in a high drug concentration at the appropriate site. Thus, the success of such a treatment requires that the particles are cytocompatible with cells. Therefore, it is encouraging that our data suggest uncoated and chitosan-coated iron oxide nanoparticles in conditions of direct contacthave satisfactory proliferative and viability effects on MCF-10A cells. Fe 3 O 4 and CS-Fe 3 O 4 NPswere also demonstrated to be cytocompatible in not direct contact cell model by using eluates solution of cell culture media in contact with MNPs to control the release of possible toxic substances.Moreover, phalloidin/DAPI staining showed no negative influence of the iron particles on the cytoskeleton. This isof great importance considering the essential role ofthe cytoskeleton in migration capability and celldivision.The biocompatible surface coating not only stabilizes the iron oxide nanoparticles, but also provides accessible surface for the biomolecular conjugation through the well-developed bioconjugation chemistry for biomedical applications [23] . In addition, multiple grafting or coating of small molecules can provide multivalent systems that exhibit significantly enhanced efficacy towards the drugs and biomolecules [24] . Hydrogel chitosan-coated MNPs with higher properties of hydrophilicity are the most optimal choice for use as anticancer agents due to their unusual beneficial properties, most notably enhanced drug availability for prolonging the drug effects in tumor tissues [24] . These results are promising for applications in biomedicine, but further in vivo and in vitro investigations of the efficacy and safety of these hydrogel magnetic nanoparticles are necessary to optimize their use in various applications like targeted drug delivery for anticancer therapy.
